These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 32438075)
1. Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis. Dong X; Lv S; Zhang X; Hao R Int Immunopharmacol; 2020 Aug; 85():106599. PubMed ID: 32438075 [TBL] [Abstract][Full Text] [Related]
2. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment. Dong X; Gu DN; Wang O; Ye Z Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of L Antigen Family Member 3 as an immune-related biomarker associated with the progression of papillary thyroid cancer. Dong X; Yang Q; Gu J; Lv S; Song D; Chen D; Song J; Zhang X; Huang D Int Immunopharmacol; 2021 Jan; 90():107267. PubMed ID: 33310661 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer. Lu C; Liao W; Huang Y; Huang Y; Luo Y BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611 [TBL] [Abstract][Full Text] [Related]
6. L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma. Song J; Jin C; Chen E; Dong X; Zhu L Biomed Res Int; 2021; 2021():6648182. PubMed ID: 33829062 [TBL] [Abstract][Full Text] [Related]
7. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Yang C; Cao F; Huang S; Zheng Y Front Immunol; 2021; 12():717505. PubMed ID: 34335633 [TBL] [Abstract][Full Text] [Related]
8. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer. Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771 [No Abstract] [Full Text] [Related]
9. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer. Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791 [TBL] [Abstract][Full Text] [Related]
10. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer. Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer. Dong X; Lv S; Gu D; Zhang X; Ye Z Front Oncol; 2020; 10():553628. PubMed ID: 33552947 [TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis. Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565 [TBL] [Abstract][Full Text] [Related]
14. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer. Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y Front Immunol; 2021; 12():781221. PubMed ID: 34950145 [TBL] [Abstract][Full Text] [Related]
15. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
16. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779 [TBL] [Abstract][Full Text] [Related]
17. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer. Wang L; Chen X; Zhang H; Hong L; Wang J; Shao L; Chen G; Wu J Front Immunol; 2022; 13():1014834. PubMed ID: 36389750 [TBL] [Abstract][Full Text] [Related]
20. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer. Huang Z; Yang Q; Huang Z Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]